Each dose contains three established molecules for your adult patients with moderate to severe COPD not adequately treated with ICS/LABA or LABA/LAMA who need triple therapy1
Each metered dose contains:
- 100mcg beclometasone
- 6mcg formoterol
- 10mcg glycopyrronium
Each delivered dose contains:
- 87mcg beclometasone
- 5mcg formoterol
- 9mcg glycopyrronium
Delivered dose is the dose leaving the mouthpiece, metered dose is the dose leaving the valve.
Trimbow contains beclometasone, formoterol and glycopyrronium in a solution formulation resulting in an aerosol with extrafine particles.1
Trimbow offers a familiar pMDI device, with twice-daily dosing[[1-3]]
Trimbow 87/5/9 is indicated for maintenance treatment in adult patients with moderate to severe COPD who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting β2-agonist or a combination of a long-acting β2-agonist and and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5.1 of the Trimbow SPC).1
Trimbow is licensed for use with an AeroChamber Plus® spacer[]
As a pMDI, Trimbow has the option to be used with an AeroChamber Plus® spacer.
- Patients already familiar with a pMDI + spacer can use the same inhalation technique with Trimbow 1,4
- The option of using Trimbow with an AeroChamber Plus® spacer can reduce oropharyngeal deposition and assist with hand-breath coordination 1,5
Inclusion of a dose counter means patients can keep track of their remaining Trimbow doses at any time.1
AeroChamber Plus® is a registered trademark of Trudell Medical International. For additional information to share with your patients who have been prescribed Trimbow please visit our Trimbow patient and carer site.